Filing Flows › AbbVie (ABBV) › Q3 2025
AbbVie (ABBV) Q3 2025 earnings results (third quarter 2025)
10-Q filed Nov 4, 2025
AbbVie (ABBV) reported revenue of $15.8B for the third quarter 2025 (Q3 2025), +9% from a year earlier and +2% from the quarter before. Operating margin was 12.1%, net earnings $188M (1.2% of revenue).
AbbVie, Q3 2025: revenue $15.8B (+9% year over year), operating margin 12.1%, net earnings $188M, operating cash flow $7.0B. The chart follows the revenue to costs, profit and cash.
| Q3 2025 | Amount | Q/Q | Y/Y |
|---|---|---|---|
| Revenue | $15.8B | +2% | +9% |
| Operating profit | $1.9B | -61% | -50% |
| Net earnings | $188M | -80% | -88% |
| Operating cash flow | $7.0B | +36% | +29% |
| Free cash flow | $6.6B | +36% | +28% |
What changed
Revenue was $15.8B in Q3 2025, up 9% year over year and up 2% from the previous quarter.
Operating profit was $1.9B, a 12.1% margin (down 14.4 points year over year). Operating profit fell $1.9B even though revenue rose $1.3B versus a year earlier, so costs grew faster than sales. Total costs grew 31% against revenue growth of 9%. The fastest-growing cost line was Other operating costs (+3168%). Net earnings were $0.19B, down 88% year over year. The effective tax rate was 73.7%.
Operating cash flow was $7.0B (up 29% year over year), 3736% of net earnings. Non-cash charges added back $2.1B of depreciation and amortization and $0.21B of share-based compensation. Working capital and other items added $4.5B. Capital expenditures of $0.38B left free cash flow of $6.6B.
Questions
What was AbbVie's revenue in the third quarter 2025?
AbbVie (ABBV) reported revenue of $15.8B for the third quarter 2025 (Q3 2025), +9% from a year earlier and +2% from the quarter before.
Was AbbVie profitable in the third quarter 2025?
Operating profit was $1.9B (12.1% of revenue) and net earnings $188M.
Source: AbbVie 10-Q on SEC EDGAR.